Who Supplies Rivaroxaban? Top Manufacturers & Their Global Buyers
India accounts for a significant share of global Rivaroxaban exports, with 221+ registered manufacturers shipping to buyers across 115+ countries — yet a handful of companies dominate the shipments. MYLAN LABORATORIES LIMITED holds the largest share at 29.5% (export value: $15.5M). Close behind, ZENTIVA PRIVATE LIMITED (6.1%, $3.2M). CARITAS HEALTHCARE PRIVATE LIMITED (5.8%, $3.1M). The Sankey diagram below maps every supplier's customer flow in detail. All figures are drawn from Indian Customs (DGFT) shipping bill records.
🏭 Market Analysis: Top Suppliers & Customer Networks
Comprehensive supplier network intelligence dashboard
Who Supplies Rivaroxaban? Top Manufacturers & Their Buyers
Flow of Rivaroxaban from leading Indian exporters to their key global customers
Supplier-Customer Network Analysis
Top Suppliers → Customer Networks
Rivaroxaban Supplier Network — Key Market Intelligence
The Rivaroxaban export market from India is led by MYLAN LABORATORIES LIMITED, which alone commands a 29.5% share, shipping $15.5M worth of product across 257 shipments. The second-largest exporter, ZENTIVA PRIVATE LIMITED, contributes $3.2M (6.1%) to the overall market. Combined, the top two suppliers alone account for 35.5% of all Rivaroxaban exports, indicating a relatively concentrated supply base.
Across all 221 tracked manufacturers, the total Rivaroxaban export value stands at $52.6M from 5.4K shipments. The market average shipment value is $9.8K. The single largest buyer relationship in terms of trade value is MYLAN IRELAND C/O ALLOGA RDC,., receiving $13.0M worth of product.
The combined buyer network spans 17 named purchasing companies, including MYLAN IRELAND C/O ALLOGA RDC,., MYLAN IRELAND, CSP, PHARMADOX HEALTHCARE LIMITED, HELVEPHARM AG and 12 others. These buyers represent pharmaceutical manufacturers, distributors, hospital procurement groups, and generic drug producers operating across multiple continents.
Market Analysis: Top Suppliers & Their Customer Networks
1MYLAN LABORATORIES LIMITED
MYLAN LABORATORIES LIMITED is the first-largest Rivaroxaban exporter from India, with a market share of 29.5% and a total export value of $15.5M across 257 shipments. Their average shipment value of $60.3K is above the market average of $9.8K, suggesting premium or bulk contract pricing.
MYLAN LABORATORIES LIMITED serves 5 named buyers in our database. MYLAN IRELAND C/O ALLOGA RDC,. is the dominant customer, accounting for 84.1% of this supplier's tracked business. Top customers include:
• MYLAN IRELAND C/O ALLOGA RDC,. — $13.0M across 216 shipments (84.1% of this supplier's total exports)
• MYLAN IRELAND C/O ALLOGA RDC,. — $911.1K across 15 shipments (5.9% of this supplier's total exports)
• MYLAN IRELAND — $653.5K across 11 shipments (4.2% of this supplier's total exports)
• CSP — $576.3K across 10 shipments (3.7% of this supplier's total exports)
• MYLAN IRELAND C/O ALLOGA RDC,. — $321.1K across 5 shipments (2.1% of this supplier's total exports)
Key Insight: MYLAN LABORATORIES LIMITED's per-shipment value of $60.3K is 514% above the market average of $9.8K, consistent with large-order contracts or value-added formulations.
2ZENTIVA PRIVATE LIMITED
ZENTIVA PRIVATE LIMITED is the second-largest Rivaroxaban exporter from India, with a market share of 6.1% and a total export value of $3.2M across 148 shipments. Their average shipment value of $21.5K is above the market average of $9.8K, suggesting premium or bulk contract pricing.
ZENTIVA PRIVATE LIMITED serves 3 named buyers in our database. PHARMADOX HEALTHCARE LIMITED is the dominant customer, accounting for 72.1% of this supplier's tracked business. Top customers include:
• PHARMADOX HEALTHCARE LIMITED — $2.3M across 107 shipments (72.1% of this supplier's total exports)
• PHARMADOX HEALTHCARE LIMITED — $782.3K across 36 shipments (24.5% of this supplier's total exports)
• HELVEPHARM AG — $108.2K across 5 shipments (3.4% of this supplier's total exports)
Key Insight: ZENTIVA PRIVATE LIMITED's per-shipment value of $21.5K is 120% above the market average of $9.8K, consistent with large-order contracts or value-added formulations.
3CARITAS HEALTHCARE PRIVATE LIMITED
CARITAS HEALTHCARE PRIVATE LIMITED is the third-largest Rivaroxaban exporter from India, with a market share of 5.8% and a total export value of $3.1M across 22 shipments. Their average shipment value of $139.3K is above the market average of $9.8K, suggesting premium or bulk contract pricing.
CARITAS HEALTHCARE PRIVATE LIMITED serves 3 named buyers in our database. TO THE PURCHASE MANAGER is the dominant customer, accounting for 85.3% of this supplier's tracked business. Top customers include:
• TO THE PURCHASE MANAGER — $2.6M across 19 shipments (85.3% of this supplier's total exports)
• F.D.E.C.A — $350.7K across 3 shipments (11.4% of this supplier's total exports)
• F.D.E.C.A — $99.1K across 1 shipments (3.2% of this supplier's total exports)
Key Insight: CARITAS HEALTHCARE PRIVATE LIMITED's per-shipment value of $139.3K is 1320% above the market average of $9.8K, consistent with large-order contracts or value-added formulations.
4DR.REDDY'S LABORATORIES LTD
DR.REDDY'S LABORATORIES LTD is the fourth-largest Rivaroxaban exporter from India, with a market share of 5.8% and a total export value of $3.0M across 131 shipments. Their average shipment value of $23.3K is above the market average of $9.8K, suggesting premium or bulk contract pricing.
DR.REDDY'S LABORATORIES LTD serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• PHARMADOX HEALTHCARE LIMITED — $1.5M across 64 shipments (49.2% of this supplier's total exports)
• DEPO PACK SNC — $663.2K across 29 shipments (21.8% of this supplier's total exports)
• MOVIANTO UK LTD — $454.1K across 20 shipments (14.9% of this supplier's total exports)
• TECHCOMBANK CHO LON — $272.5K across 12 shipments (8.9% of this supplier's total exports)
• DR.REDDY'S LABORATOR — $158.6K across 7 shipments (5.2% of this supplier's total exports)
Key Insight: DR.REDDY'S LABORATORIES LTD's per-shipment value of $23.3K is 137% above the market average of $9.8K, consistent with large-order contracts or value-added formulations.
5APOTEX RESEARCH PRIVATE LIMITED
APOTEX RESEARCH PRIVATE LIMITED is the fifth-largest Rivaroxaban exporter from India, with a market share of 4.3% and a total export value of $2.3M across 54 shipments. Their average shipment value of $42.1K is above the market average of $9.8K, suggesting premium or bulk contract pricing.
APOTEX RESEARCH PRIVATE LIMITED serves 3 named buyers in our database. APOTEX INC is the dominant customer, accounting for 55.7% of this supplier's tracked business. Top customers include:
• APOTEX INC — $1.3M across 30 shipments (55.7% of this supplier's total exports)
• APOTEX INC — $506.4K across 12 shipments (22.3% of this supplier's total exports)
• APOTEX INC,-4100 WESTON ROAD — $499.7K across 12 shipments (22.0% of this supplier's total exports)
Key Insight: APOTEX RESEARCH PRIVATE LIMITED's per-shipment value of $42.1K is 329% above the market average of $9.8K, consistent with large-order contracts or value-added formulations.
6MICRO LABS LIMITED
MICRO LABS LIMITED is the fifth-largest Rivaroxaban exporter from India, with a market share of 2.1% and a total export value of $1.1M across 141 shipments. Their average shipment value of $7.7K is below the market average of $9.8K, reflecting a high-volume, competitive pricing strategy.
MICRO LABS LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• LABOREX TANZANIA LTD — $315.9K across 41 shipments (29.0% of this supplier's total exports)
• BROWN AND BURK UK LI — $276.7K across 36 shipments (25.4% of this supplier's total exports)
• E.P.DIS — $235.6K across 30 shipments (21.6% of this supplier's total exports)
• MICRO NOVA PHARMACEU — $133.3K across 17 shipments (12.2% of this supplier's total exports)
• E.P.DIS — $128.0K across 17 shipments (11.7% of this supplier's total exports)
Key Insight: MICRO LABS LIMITED operates with high shipment frequency (141 shipments) at a per-shipment value of $7.7K, indicating a broad distribution network with many smaller, regular orders.
From Indian Factories to Global Pharmacies — How Rivaroxaban Flows
Once Rivaroxaban leaves the manufacturing plants of companies like MYLAN LABORATORIES LIMITED and ZENTIVA PRIVATE LIMITED, it travels to 5 destination markets with a combined import value of $52.6M. Netherlands absorbs the largest share at 29.9% ($15.7M), followed by Malta (9.6%) and Ecuador (6.2%).
In Netherlands — the top destination — named importers include MYLAN IRELAND C/O ALLOGA RDC,, MYLAN IRELAND C/O ALLOGA RDC,., MYLAN IRELAND. In Malta, key buyers are PHARMADOX HEALTHCARE LTD, PHARMADOX HEALTHCARE LIMITED.
This geographic spread reflects Rivaroxaban's role as an essential active pharmaceutical ingredient (API) and finished dosage form — sourced primarily from India due to its cost-competitive, WHO-compliant manufacturing base. The Sankey diagram below maps these destination countries to their named importers in detail.
🌍 Market Analysis: Top Importing Countries & Importers
Comprehensive geographic market intelligence dashboard
Where Does Rivaroxaban Go? Top Importing Countries & Their Buyers
Trade flow of Rivaroxaban exports from India — top destination countries and the named companies importing it
Geographic Market Flow Analysis
Top Countries → Global Importers
Market Analysis: Top Importing Countries & Their Importers
1Netherlands
Netherlands ranks as the first-largest destination for Rivaroxaban imports from India, with a total trade value of $15.7M across 162 shipments — representing a 29.9% share of all Rivaroxaban exports. The average shipment value of $97.0K is above the global average of $9.8K, indicating high-value procurement contracts or branded formulations. This market is served by 3 tracked buyers.
Named Rivaroxaban importers in Netherlands: MYLAN IRELAND C/O ALLOGA RDC, is the largest buyer, accounting for 84.3% ($13.3M) of this market's total imports.
• MYLAN IRELAND C/O ALLOGA RDC, — $13.3M (84.3% of Netherlands's total)
• MYLAN IRELAND C/O ALLOGA RDC,. — $911.1K (5.8% of Netherlands's total)
• MYLAN IRELAND — $653.5K (4.2% of Netherlands's total)
Key Insight: Netherlands's per-shipment average of $97.0K (889% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Netherlands is a key market for Rivaroxaban imports from India.
2Malta
Malta ranks as the second-largest destination for Rivaroxaban imports from India, with a total trade value of $5.0M across 244 shipments — representing a 9.6% share of all Rivaroxaban exports. The average shipment value of $20.7K is above the global average of $9.8K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.
Named Rivaroxaban importers in Malta: PHARMADOX HEALTHCARE LTD is the largest buyer, accounting for 77.9% ($3.9M) of this market's total imports.
• PHARMADOX HEALTHCARE LTD — $3.9M (77.9% of Malta's total)
• PHARMADOX HEALTHCARE LIMITED — $1.1M (20.8% of Malta's total)
Key Insight: Malta's per-shipment average of $20.7K (111% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Malta is a key market for Rivaroxaban imports from India.
3Ecuador
Ecuador ranks as the third-largest destination for Rivaroxaban imports from India, with a total trade value of $3.2M across 9 shipments — representing a 6.2% share of all Rivaroxaban exports. The average shipment value of $360.0K is above the global average of $9.8K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.
Named Rivaroxaban importers in Ecuador: TO THE PURCHASE MANAGER is the largest buyer, accounting for 84.1% ($2.7M) of this market's total imports.
• TO THE PURCHASE MANAGER — $2.7M (84.1% of Ecuador's total)
Key Insight: Ecuador's per-shipment average of $360.0K (3570% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Ecuador is a key market for Rivaroxaban imports from India.
4Canada
Canada ranks as the fourth-largest destination for Rivaroxaban imports from India, with a total trade value of $3.2M across 54 shipments — representing a 6.0% share of all Rivaroxaban exports. The average shipment value of $58.6K is above the global average of $9.8K, indicating high-value procurement contracts or branded formulations. This market is served by 3 tracked buyers.
Named Rivaroxaban importers in Canada: APOTEX INC is the largest buyer, accounting for 40.0% ($1.3M) of this market's total imports.
• APOTEX INC — $1.3M (40.0% of Canada's total)
• APOTEX INC, — $506.4K (16.0% of Canada's total)
• APOTEX INC,-4100 WESTON ROAD — $499.7K (15.8% of Canada's total)
Key Insight: Canada's per-shipment average of $58.6K (498% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Canada is a key market for Rivaroxaban imports from India.
5Brazil
Brazil ranks as the fifth-largest destination for Rivaroxaban imports from India, with a total trade value of $2.6M across 35 shipments — representing a 5.0% share of all Rivaroxaban exports. The average shipment value of $75.2K is above the global average of $9.8K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.
Named Rivaroxaban importers in Brazil: BIOLAB FARMA GENERICO is the largest buyer, accounting for 30.8% ($811.8K) of this market's total imports.
• BIOLAB FARMA GENERICO — $811.8K (30.8% of Brazil's total)
• TORRENT DO BRASIL LTDA — $688.7K (26.2% of Brazil's total)
Key Insight: Brazil's per-shipment average of $75.2K (667% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Brazil is a key market for Rivaroxaban imports from India.
People Also Ask — Rivaroxaban Supplier & Trade Network
Who are the top suppliers of Rivaroxaban from India?+
Which companies buy Rivaroxaban from Indian manufacturers?+
Where does Rivaroxaban exported from India go?+
What is the market share of the top Rivaroxaban supplier from India?+
What is the average shipment value for Rivaroxaban exports from India?+
Is Rivaroxaban manufactured in India and exported globally?+
Which country imports the most Rivaroxaban from India?+
Who are the buyers of Rivaroxaban in Malta?+
How concentrated is the Rivaroxaban supplier market in India?+
How do I find verified buyers for Rivaroxaban in specific countries?+
Rivaroxaban Trade Network — Key Takeaways
- 1MYLAN LABORATORIES LIMITED is India's dominant Rivaroxaban exporter with a 29.5% market share and $15.5M in total exports — making it the single most important sourcing entity in this market.
- 2The top 221 suppliers collectively account for 53.5% of all tracked Rivaroxaban exports, with a combined trade value of $52.6M.
- 3Netherlands is the largest destination market, absorbing 29.9% of India's Rivaroxaban exports ($15.7M). Malta (9.6%) and Ecuador (6.2%) follow.
- 4With 5.4K total shipments averaging $9.8K each, the Rivaroxaban export trade from India reflects both bulk API supply and finished dosage form distribution.
- 5Verified buyers across the network include MYLAN IRELAND C/O ALLOGA RDC,., MYLAN IRELAND C/O ALLOGA RDC,., PHARMADOX HEALTHCARE LIMITED, PHARMADOX HEALTHCARE LIMITED — representing a diverse base of pharmaceutical importers, distributors, and generic drug manufacturers globally.
Network Overview
Supplier Network
Country Network
Network Insights
Top supplier: 5 customers
6 suppliers → 115 countries
Network value: $52.6M
Related Analysis
Market Intelligence
Latest developments and market context
Detailed market intelligence for Rivaroxaban — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Network Construction: Supplier-to-buyer trade relationships constructed from verified shipment pairs in Indian Customs (DGFT) records for Rivaroxaban.
- 2.Flow Mapping: 221 Indian manufacturers mapped to their international buyer networks using consignee name normalization.
- 3.Value Aggregation: Trade value per supplier-buyer link aggregated from 5,361 individual shipment records. Values are FOB in USD.
- 4.Geographic Clustering: Buyer networks clustered across 115 destination countries to identify geographic concentration patterns.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
5,361 Verified Shipments
221 manufacturers in network
Expert-Reviewed
By pharmaceutical trade specialists